Cell tissue on the monitor of a fluorescence microscope.

B01

Targeted nanoparticle mediated delivery of nucleic acids into muscle stem cells for prevention of critical illness myopathy
Cell tissue on the monitor of a fluorescence microscope.

According to studies, 25% of patients in intensive care units develop Critical Illness Myopathy (CIM), which is not yet therapeutically treatable. Muscle inflammation is associated with the development of CIM in sepsis patients. There is also new evidence that inflammatory signaling pathways contribute to age-related impairments of muscle stem cells, also known as satellite cells (SCs). Upon injury, these cells are activated and finally differentiate into myotubes. Rudolph's team recently identified a Hox protein gene fragment, HoxM, which has the potential to reduce inflammatory and senescence signals, thereby improving the proliferative potential of activated stem cells in culture. Inhibition of the Hox genes by the newly discovered HoxM fragment could thus lead to a reduction of inflammation in sepsis induced CIM. For this purpose, multifunctional nanoparticles for the transport of mRNA encoding a therapeutic Hox gene fragment (HoxM) into muscle stem cells are being developed (Träger lab). The mRNA is encapsulated in cationic particles, which are then coated with anionic counter-polymers that can be functionalized with stealth polymers and/or target molecules. Different aspects such as cellular targeting and uptake of the nanoparticle, endosomal release and intercellular delivery of HoxM are investigated as well as the influence of the particles on muscle stem cell proliferation and the therapeutic effect of nanoparticle-mediated gene delivery.

Grafik Projekt B01 Grafik Projekt B01 Image: A. Träger

Principle investigators

Dr. Anja Träger Dr. Anja Träger Image: werbeagentur redcat designgroup

Dr. Anja Träger

Particle Formulation Group (PFG)
Jena Center for Soft Matter (JCSM)
Friedrich Schiller University Jena
Philosophenweg 7
07743 Jena
Phone: +49 3641 9-48599
anja.traeger@uni-jena.de

Prof. Dr. Lenhard K. Rudolph Prof. Dr. Lenhard K. Rudolph Image: Prof. Dr. Lenhard K. Rudolph

Prof. Dr. Karl Lenhard Rudolph

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)
Beutenbergstraße 11
07745 Jena
Phone: +49 3641 65-6818
lenhard.rudolph@leibniz-fli.de

Staff

Jana Solomun Jana Solomun Image: Jana Solomun

Jana Solomun

Particle Formulation Group (PFG)
Jena Center for Soft Matter (JCSM)
Friedrich Schiller University Jena
Philosophenweg 7
07743 Jena
Phone: +49 3641 9-48575
jana.solomun@uni-jena.de

Prosper Mapfumo

Particle Formulation Group (PFG)
Jena Center for Soft Matter (JCSM)
Friedrich Schiller University Jena
Philosophenweg 7
07743 Jena
Phone: +49 3641 9-48587
prosper.mapfumo@uni-jena.de

Thomas André

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)
Beutenbergstraße 11
07745 Jena
Thomas.Andre@leibniz-fli.de

Share this page
Friedrich Schiller University on social media:
Studying amid excellence:
Top of the page